Results 121 to 130 of about 214,432 (171)

Rapid Extensively Drug-Resistant (XDR) TB Diagnosis: An In-House DNA Biochip for Drug Resistance Detection and Mutation Profiling of <i>Mycobacterium tuberculosis</i>. [PDF]

Can J Infect Dis Med Microbiol
Jain B, Kulkarni S, Baghel NS.
europepmc   +1 more source

Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]

JAC Antimicrob Resist
Klingmüller A, Zuber S, Hoffmann AM, Köhler N, Suárez I, Preßel T, Niemann S, Dreyer V, Decosterd LA, Choong E, Schütz B, Friesen I, Rybniker J.   +12 more
europepmc   +1 more source

A historical budget impact and expenditure analysis of meropenem and clavulanate-based treatment for adults with XDR-TB at a specialised TB hospital in South Africa. [PDF]

S Afr Fam Pract (2004)
Mgoqi BB, McGee SA, Suleman F.
europepmc   +1 more source

Performance of the low-cost phenotypic thin-layer agar MDR/XDR-TB Colour Test (first generation, 1G, Color Plate Test) for identifying drug-resistant Mycobacterium tuberculosis isolates in a resource-limited setting. [PDF]

BMC Microbiol
Mebrat B, Garcia JI, Woldeamanuel Y, Adane K, Hicks A, Tilahun M, Neway S, Oluma L, Atnafu A, Gelfond J, Evans CA, Torrelles JB, Wang SH, Wassie L.   +13 more
europepmc   +2 more sources

Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB. [PDF]

Antibiotics (Basel)
Zaporojan N, Hodișan R, Pantiș C, Csep AN, Zaporojan C, Zaha DC.   +5 more
europepmc   +1 more source

Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning. [PDF]

BMC Infect Dis
Tan EL, Qin Y, Yang J, Li XJ, Liu TQ, Yang GB, Li YJ, Zhang ZZ, Lu ZH, Wang JC, Zheng JX, Zhang SX.   +11 more
europepmc   +1 more source

Epidemiology and clinical managment of XDR-TB: a systematic review.

, 2009
: Extensively drug-resistant tuberculosis (XDR-TB) is present in all regions and poses serious challenges for public health and clinical management. Laboratory diagnosis is difficult and little evidence exists to guide clinicians in treating people with ...
MATTEELLI A, MIGLIORI G., CIRILLO D, ZELLWEGER J, RUESCH GERDES S, TOUNGOUSSOVA O, RICHARDSON M, LANGE C, CENTIS R, SPANEVELLO A, SOTGIU G, FERRARA, Giovanni   +11 more
core  

Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study. [PDF]

Infect Dis Ther, 2021
Shi L, Gao J, Gao M, Deng P, Chen S, He M, Feng W, Yang X, Huang Y, He F, Hu Y, Lei L, Li X, Du J, Hu X, Liu Z, Tang P, Han J, Wang H, Han Y, Shu W, Sun Y, Pei Y, Liu Y.   +23 more
europepmc   +1 more source

Effect of Bdq-Containing Regimen and Molecular Detection of Bdq Resistance among Pre-XDR-TB Patients with Unfavorable Outcomes. [PDF]

Int J Gen Med
Ding F, Li S, Liu X, Shao G, Su Y, Qian Y, Mao Z, Zeng J, Lu S, Fang M.   +9 more
europepmc   +1 more source

Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB. [PDF]

Curr HIV/AIDS Rep, 2020
Ignatius EH, Swindells S.
europepmc   +1 more source